Sen. Bill Cassidy (R-LA) (Francis Chung/POLITICO via AP Images)
January 18, 2024 03:26 PM EST
Pharma
Law

Sen­a­tor ques­tions CVS, Wal­greens about growth in 340B par­tic­i­pa­tion

Zachary Brennan

Senior Editor

Sen. Bill Cas­sidy (R-LA), a rank­ing mem­ber on the Health, Ed­u­ca­tion, La­bor and Pen­sions Com­mit­tee, re­quest­ed in­for­ma­tion from CVS Health and Wal­greens Boots Al­liance about …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times